Thomas Ernst

Prof. Dr. Thomas Ernst


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
ULUnhee Lim
Unhee Lim
KMKristine R. Monroe
Kristine R. Monroe
SBSteve Buchthal
Steve Buchthal
BFBo Fan
Bo Fan
ICIona Cheng
Iona Cheng
LMLoïc Le Marchand
Loïc Le Marchand

17 April 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
PDF file
MSMuhammad G. Saleh
Muhammad G. Saleh
RERichard A. E. Edden
Richard A. E. Edden
LCLinda Chang
Linda Chang
TEThomas Ernst
Thomas Ernst
In vivo proton magnetic resonance spectroscopy and spectroscopic imaging (MRS/MRSI) are valuable tools to study normal and abnormal human brain physiology. However, they are sensitive to motion, due to strong crusher gradients, long acquisition times, reliance on high magnetic field homogeneity, and particular acquisition methods such as spectral editing. The effects of motion include incorrect spatial localization, phase fluctuations, incoherent averaging, line broadening, and ultimately quantitation errors. Several retrospective methods have been proposed to correct motion‐related artifacts. Recent advances in hardware also allow prospective (real‐time) correction of the effects of motion, including adjusting voxel location, center frequency, and magnetic field homogeneity. This article reviews prospective and retrospective methods available in the literature and their implications for clinical MRS/MRSI. In combination, these methods can attenuate or eliminate most motion‐related artifacts and facilitate the acquisition of high‐quality data in the clinical research setting.

4 August 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
TEThomas Ernst
Thomas Ernst
MRMeghann C Ryan
Meghann C Ryan
HLHua-Jun Liang
Hua-Jun Liang
JWJustin P Wang
Justin P Wang
ECEric Cunningham
Eric Cunningham
LCLinda Chang
Linda Chang
Background: The aim of this study was to determine whether neurometabolite abnormalities indicating neuroinflammation and neuronal injury are detectable in individuals post–coronavirus disease 2019 (COVID-19) with persistent neuropsychiatric symptoms. Methods: All participants were studied with proton magnetic resonance spectroscopy at 3 T to assess neurometabolite concentrations (point-resolved spectroscopy, relaxation time/echo time = 3000/30 ms) in frontal white matter (FWM) and anterior cingulate cortex–gray matter (ACC-GM). Participants also completed the National Institutes of Health Toolbox cognition and motor batteries and selected modules from the Patient-Reported Outcomes Measurement Information System. Results: Fifty-four participants were evaluated: 29 post–COVID-19 (mean ± SD age, 42.4 ± 12.3 years; approximately 8 months from COVID-19 diagnosis; 19 women) and 25 controls (age, 44.1 ± 12.3 years; 14 women). When compared with controls, the post–COVID-19 group had lower total N-acetyl compounds (tNAA; ACC-GM: −5.0%, P = .015; FWM: –4.4%, P = .13), FWM glutamate + glutamine (–9.5%, P = .001), and ACC-GM myo-inositol (−6.2%, P = .024). Additionally, only hospitalized patients post–COVID-19 showed age-related increases in myo-inositol, choline compounds, and total creatine (interaction P = .029 to <.001). Across all participants, lower FWM tNAA and higher ACC-GM myo-inositol predicted poorer performance on several cognitive measures (P = .001–.009), while lower ACC-GM tNAA predicted lower endurance on the 2-minute walk (P = .005). Conclusions: In participants post–COVID-19 with persistent neuropsychiatric symptoms, the lower-than-normal tNAA and glutamate + glutamine indicate neuronal injury, while the lower-than-normal myo-inositol reflects glial dysfunction, possibly related to mitochondrial dysfunction and oxidative stress in Post-COVID participants with persistent neuropsychiatric symptoms.

15 August 2022 in NeuroImmune Pharmacology and Therapeutics
Verified
Journal Article
Open access
PDF file
MSMuhammad G. Saleh
Muhammad G. Saleh
LCLinda Chang
Linda Chang
HLHuajun Liang
Huajun Liang
MRMeghann C. Ryan
Meghann C. Ryan
ECEric Cunningham
Eric Cunningham
TEThomas Ernst
Thomas Ernst
Objectives: Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is associated with lower plasma glutathione (GSH) levels due to oxidative stress. However, plasma levels may not reflect brain GSH levels. Individuals with post-acute sequelae of COVID-19 (PASC) have a higher prevalence of cognitive fatigue, which might be related to altered brain γ-aminobutyric-acid (GABA) levels. Hence, our study aims to measure the brain GSH and GABA levels in PASC. Methods: 29 PASC participants and 24 uninfected controls were recruited for this study. Each was evaluated with detailed neuropsychiatric assessments and an edited proton MRS (Hadamard Encoding and Reconstruction of Mega-Edited Spectroscopy, HERMES) method to measure GABA and GSH concentrations in predominantly grey matter (GM) and predominantly white matter (WM) brain frontal voxels. Results: PASC participants were 219 ± 137 days since their COVID-19 diagnosis. Nine individuals with PASC were hospitalized. Compared to controls, individuals with PASC had similar levels of GABA in both brain regions, but lower GSH and greater age-related GSH decline in the frontal GM region. Conclusions: The lower-than-normal frontal GM GSH level in participants with PASC suggest that they have ongoing oxidative stress in the brain, and that older individuals may be even more vulnerable to oxidative stress.

15 May 2024 in Algorithms
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
XWXiaoke Wang
Xiaoke Wang
MRMichael Rawson
Michael Rawson
RBRadu Balan
Radu Balan
EHEdward Herskovits
Edward Herskovits
TEThomas Ernst
Thomas Ernst
Purpose: Motion-induced magnetic resonance imaging (MRI) artifacts can deteriorate image quality and reduce diagnostic accuracy, but motion by human subjects is inevitable and can even be caused by involuntary physiological movements. Deep-learning-based motion correction methods might provide a solution. However, most studies have been based on directly applying existing models, and the trained models are rarely accessible. Therefore, we aim to develop and evaluate a deep-learning-based method (Motion Correction-Net, or MC-Net) for suppressing motion artifacts in brain MRI scans. Methods: A total of 57 subjects, providing 20,889 slices in four datasets, were used. Furthermore, 3T 3D sagittal magnetization-prepared rapid gradient-echo (MP-RAGE) and 2D axial fluid-attenuated inversion-recovery (FLAIR) sequences were acquired. The MC-Net was derived from a UNet combined with a two-stage multi-loss function. T1-weighted axial brain images contaminated with synthetic motions were used to train the network to remove motion artifacts. Evaluation used simulated T1- and T2-weighted axial, coronal, and sagittal images unseen during training, as well as T1-weighted images with motion artifacts from real scans. The performance indices included the peak-signal-to-noise ratio (PSNR), the structural similarity index measure (SSIM), and visual reading scores from three blinded clinical readers. A one-sided Wilcoxon signed-rank test was used to compare reader scores, with p < 0.05 considered significant. Intraclass correlation coefficients (ICCs) were calculated for inter-rater evaluations. Results: The MC-Net outperformed other methods in terms of PSNR and SSIM for the T1 axial test set. The MC-Net significantly improved the quality of all T1-weighted images for all directions (i.e., the mean SSIM of axial, sagittal, and coronal slices improved from 0.77, 0.64, and 0.71 to 0.92, 0.75, and 0.84; the mean PSNR improved from 26.35, 24.03, and 24.55 to 29.72, 24.40, and 25.37, respectively) and for simulated as well as real motion artifacts, both using quantitative measures and visual scores. However, MC-Net performed poorly for images with untrained T2-weighted contrast because the T2 contrast was unseen during training and is different from T1 contrast. Conclusion: The proposed two-stage multi-loss MC-Net can effectively suppress motion artifacts in brain MRI without compromising image quality. Given the efficiency of MC-Net (with a single-image processing time of ~40 ms), it can potentially be used in clinical settings.

4 November 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
DHDonald J Hagler
Donald J Hagler
SHSean N. Hatton
Sean N. Hatton
CMCarolina Makowski
Carolina Makowski
MCM. Daniela Cornejo
M. Daniela Cornejo
DFDamien A Fair
Damien A Fair
ADAnders M. Dale
Anders M. Dale
The Adolescent Brain Cognitive Development (ABCD) Study is an ongoing, nationwide study of the effects of environmental influences on behavioral and brain development in adolescents. The ABCD Study is a collaborative effort, including a Coordinating Center, 21 data acquisition sites across the United States, and a Data Analysis and Informatics Center (DAIC). The main objective of the study is to recruit and assess over eleven thousand 9-10-year-olds and follow them over the course of 10 years to characterize normative brain and cognitive development, the many factors that influence brain development, and the effects of those factors on mental health and other outcomes. The study employs state-of-the-art multimodal brain imaging, cognitive and clinical assessments, bioassays, and careful assessment of substance use, environment, psychopathological symptoms, and social functioning. The data will provide a resource of unprecedented scale and depth for studying typical and atypical development. Here, we describe the baseline neuroimaging processing and subject-level analysis methods used by the ABCD DAIC in the centralized processing and extraction of neuroanatomical and functional imaging phenotypes. Neuroimaging processing and analyses include modality-specific corrections for distortions and motion, brain segmentation and cortical surface reconstruction derived from structural magnetic resonance imaging (sMRI), analysis of brain microstructure using diffusion MRI (dMRI), task-related analysis of functional MRI (fMRI), and functional connectivity analysis of resting-state fMRI. Highlights: An overview of the MRI processing pipeline for the ABCD Study A discussion on the challenges of large, multisite population studies A methodological reference for users of publicly shared data from the ABCD Study